Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
Status:
Terminated
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether TH-302 in combination with pemetrexed is
safe and effective in the treatment of non-squamous non-small cell lung cancer.